Treatments Beyond Treatment: ASCO's Expanding Vision of Cancer Care
Executive Summary
Cancer's chief professional practice organization, the American Society of Clinical Oncology (ASCO), is working to transform the post-treatment pathway for survivors of cancer. It is part of an overall movement in the cancer community emphasizing the importance of making current treatments work better for more patients.
You may also be interested in...
Academia Meets The Market – Part Two
New drug development is an increasingly communal enterprise. In Vivo examines how one major US academic institution – the University of California at Los Angeles (UCLA) – is expanding its range of research contacts to open new areas of therapy and shorten the transition from bench to the bedside.
Academia Meets The Market – Part One
New drug development is an increasingly communal enterprise. In Vivo examines how one major US academic institution – the University of California at Los Angeles (UCLA) – is expanding its range of research contacts to open new areas of therapy and shorten the transition from bench to the bedside. Its commercial impact is considerable: over the past two decades, private-sector VC’s have invested more than $2bn in UCLA-backed innovations, with 26 start-ups launched through the university in 2019 alone. Amir Naiberg, UCLA’s point man on technology transfer, explains the factors that have made the university a successful advocate for partnerships that produce results for patients.
Seeing The Strength In Synergy
In this installment of VC Playbook, profiling venture capital strategies in biopharma and medtech, In Vivo talks to Sofinnova Partners' Graziano Seghezzi about market access trends, Italy’s growing biotech offering and the perils of “health nationalism” to business partnering in the aftermath of COVID-19.
Need a specific report? 1000+ reports available
Buy Reports